Hostname: page-component-77c89778f8-fv566 Total loading time: 0 Render date: 2024-07-20T08:20:07.876Z Has data issue: false hasContentIssue false
  • English
  • Français

Overcoming Barriers to Establishing an Inpatient Vaccination Program for Pneumococcus Using Standing Orders

Published online by Cambridge University Press:  21 June 2016

Donald B. Middleton ,
Dwight E. Fox ,
Mary Patricia Nowalk ,
Susan J. Skledar ,
Denise R. Sokos ,
Richard K. Zimmerman ,
Kelly A. Ervin  and
Chyongchiou J. Lin
Donald B. Middleton*
Affiliation:
Department of Family Medicine and Clinical Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania
Dwight E. Fox
Affiliation:
Department of Family Medicine and Clinical Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania
Mary Patricia Nowalk
Affiliation:
Department of Family Medicine and Clinical Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania
Susan J. Skledar
Affiliation:
School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania
Denise R. Sokos
Affiliation:
School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania
Richard K. Zimmerman
Affiliation:
Department of Family Medicine and Clinical Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania
Kelly A. Ervin
Affiliation:
Department of Pharmacy and Therapeutics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Chyongchiou J. Lin
Affiliation:
Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania
*
Department of Family Medicine UPMC St. Margaret, 815 Freeport Rd., Pittsburgh, PA 15215, middletondb@upmc.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

To identify and classify barriers to establishing a standing orders program (SOP) for adult pneumococcal vaccination in acute care inpatient facilities and to provide recommendations for overcoming these roadblocks. Vaccination rates in hospitals with SOPs are generally higher than those in hospitals that require individual physician orders. The array of solutions drawn from our experience in different hospital settings should permit many types of facilities to anticipate and overcome barriers, allowing a smoother transition from initiation to successful implementation of an inpatient pneumococcal vaccination SOP.

Design:

Descriptive study of barriers and solutions encountered during implementation of a pneumococcal vaccination SOP in three hospitals of the University of Pittsburgh Medical Center Health System (UPMC) and in the scientific literature.

Setting:

As of 2004, two UPMC tertiary-care hospitals and one UPMC community hospital had incorporated SOPs into existing physician order-driven programs for inpatient vaccination with pneumococcal polysaccharide vaccine.

Results:

Barriers were identified at each step of implementation and categorized as patient related, provider related, or institutional. Based on a process of continual review and revision of our programs in response to encountered barriers, steps were taken to overcome these impediments.

Conclusions:

A strong commitment by key individuals in the facility's administration including a physician champion; ongoing, persistent efforts to educate and train staff; and close monitoring of the vaccination rate were essential for successful implementation of a SOP for pneumococcal vaccination of eligible inpatients. Legal statutes and evaluations of external hospital-rating associations regarding the effectiveness of the vaccination program were major motivating factors in its success.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 26 , Issue 11 , November 2005 , pp. 874 - 881
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46:1–24.Google Scholar
2.Whitney, CG, Farley, MM, Hadler, J, et al.Increasing prevalence of multi-drug resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000;343:1917–1924.Google Scholar
3.Shapiro, ED, Berg, AT, Austrian, R, et al.The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453–1460.Google Scholar
4.Farr, BM, Johnston, BL, Cobb, DK, et al.Preventing pneumococcal bacteremia in patients at risk: results of a matched case-control study. Arch Intern Med 1995;155:2336–2340.Google Scholar
5.Centers for Disease Control and Prevention. Notice to readers: facilitating influenza and pneumococcal vaccination through standing orders programs. MMWR 2003;52:68–69.Google Scholar
6.Centers for Disease Control and Prevention. Racial/ethnic disparities in influenza and pneumococcal vaccination levels among persons aged > or - 65 years: United States, 1989-2001. MMWR 2003;52:958–962.+or+-+65+years:+United+States,+1989-2001.+MMWR2003;52:958–962.>Google Scholar
7.U.S. Department of Health and Human Services. Healthy People 2010: With Understanding and Improving Health and Objectives for Improving Health, ed. 2. Washington, DC: U.S. Government Printing Office; 2000.Google Scholar
8.Fedson, DS, Baldwin, JA. Previous hospital care as a risk factor for pneumonia: implications for immunization with pneumococcal vaccine. JAMA 1982;248:1989–1995.Google Scholar
9.Nichol, KL. Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults. Am J Med 1998;105:385–392.Google Scholar
10.Centers for Medicare and Medicaid, Series, H. Medicare and Medicaid programs, conditions of participation: immunization standards for hospitals, long-term care facilities, and home health agencies. Final rule with comment period. Fed Regist 2002;67:61808–61814.Google Scholar
11.Hempstead, K, Bresnitz, E, Howell-White, S, Crabtree, D, Scotto Rosato, N. Use of a state regulation for adult vaccination. Am J Prev Med 2004;26:311–314.CrossRefGoogle ScholarPubMed
12.Pennsylvania State Legislature. Elderly Immunization Act. Harris-burg, PA: Pennsylvania State Legislature; July 3, 2004. Available at www.legis.state.pa.us/WU01/LI/BI/BH/2003/0/SB0769.HTMState. Accessed March 2, 2005.Google Scholar
13.Nowalk, MP, Middleton, DB, Zimmerman, RK, Hess, MM, Skledar, SJ, Jacobs, MA. Increasing pneumococcal vaccination rates among hospitalized patients. Infect Control Hosp Epidemiol 2003;24:526–531.Google Scholar
14.Skledar, SJ, Hess, MM, Ervin, KA, et al.Designing a hospital-based pneumococcal vaccination program. Am J Health Syst Pharm 2003;60:1471–1476.Google Scholar
15.Centers for Disease Control and Prevention. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations: United States, 1996. MMWR 1999;48:886–889.Google Scholar
16.Meyers, S. Workforce: a difficult prescription to fill. Hospitals search for new solutions to relieve the pharmacist shortage. Trustee 2003;56:24–26.Google Scholar
17.Cooksey, JA, Knapp, KK, Walton, SM, Cultice, JM. Challenges to the pharmacist profession from escalating pharmaceutical demand. Health Aff (Millwood) 2002;21:182–188.CrossRefGoogle Scholar
18.American Hospital Association, Commission on Workforce for Hospitals and Health Systems. In Our Hands: How Hospital Leaders Can Build a Thriving Workforce. Chicago: American Hospital Association; 2002.Google Scholar
19.First Consulting Group. New Report Shows Nationwide Effects of Workforce Shortage. Chicago: American Hospital Association; 2001. Available at www.aha.org/aha/key_issues/workforce/resources/Content/Fcg WorkforceReport.pdf. Accessed March 2, 2005.Google Scholar
20.Rhew, DC, Glassman, PA, Goetz, MB. Improving pneumococcal vaccine rates: nurse protocols versus clinical reminders. J Gen Intern Med 1999;14:351–356.CrossRefGoogle ScholarPubMed
21.Centers for Disease Control and Prevention. Use of standing orders programs to increase adult vaccination rates. MMWR 2000;49:15–26.Google Scholar
22.Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases, ed. 8. Washington, DC: Public Health Foundation; 2004.Google Scholar
23.Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46:1–24.Google Scholar
24.Metersky, ML, Mennone, JZ, Fine, JM. Factors inhibiting use of the pneumococcal polysaccharide vaccine: a survey of Connecticut physicians. Conn Med 1998;62:649–654.Google ScholarPubMed
25.Bloom, HG, Wheeler, DA, Linn, J. A managed care organization's attempt to increase influenza and pneumococcal immunizations for older adults in an acute care setting. J Am Geriatr Soc 1999;47:106–110.CrossRefGoogle Scholar
26.Gardner, P, Eickhoff, T, Poland, GA, et al.Adult immunizations. Ann Intern Med 1996;124:35–40.CrossRefGoogle ScholarPubMed
27.Lackner, TE, Hamilton, R, Hill, J, Davey, C, Guay, DR. Pneumococcal polysaccharide revaccination: immunoglobulin G seroconversion, persistence, and safety in frail, chronically ill older subjects. J Am Geriatr Soc 2003;51:240–245.CrossRefGoogle ScholarPubMed
28.Torling, J, Hedlund, J, Konradsen, HB, Ortqvist, A. Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia. Vaccine 2003;22:96–103.Google Scholar
29.Hanson, D. Intramuscular injection injuries and complications. Textbook General Practice 1963;27:109–115.Google Scholar
30.Cabana, MD, Rand, CS, Powe, NR, et al.Why don't physicians follow clinical practice guidelines? JAMA 1999;282:1458–1465.Google Scholar
31.MacDonald, R, Baken, L, Nelson, A, Nichol, KL. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999;16:173–177.Google Scholar
32.Zimmerman, RK, Raymund, M, Janosky, JE, Nowalk, MP, Fine, MJ. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 2003;21:1486–1491.Google Scholar
33.Jackson, LA, Benson, P, Sneller, VP. Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA 1999;281:243–244.CrossRefGoogle ScholarPubMed
34.Centers for Medicare & Medicaid Services. Medicare Preventive Services: Influenza/Pneumococcal Campaign. Baltimore, MD: Centers for Medicare & Medicaid Services; 2005. Available at www.cms.hhs.gov/preventiveservices/2.asp. Accessed March 3, 2005.Google Scholar
35.Anient, A, Baltussen, R, Duru, G, et al.Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 Western European countries. Clin Infect Dis 2000;31:444–450.Google Scholar
36.Sisk, J, Moskowitz, AJ, Whang, W, et al.Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997;278:1333–1339.Google Scholar
37.Moore, RA, Wiffen, PJ, Lipsky, BA. Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BMC Fam Pract 2000;1:1–10. Available at www.biomedcentral.com/1471-2296/1/11[1]. Accessed March 7, 2005.Google Scholar
38.Watson, L, Wilson, BJ, Waugh, N. Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults. Vaccine 2002;20:2166–2173.Google Scholar
39.Crabtree, BF, Miller, WL, Aita, VA, Flocke, SA, Stange, KC. Primary care practice organization and preventive services delivery: a qualitative analysis. J Fam Pract 1998;46:403–409.Google Scholar